Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada Canada Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada Canada Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
a person holding a baby ;

Thalassemia

Learn how Neria™ infusion set products are used for thalassemia treatment. Read the Instructions For Use (IFU) for detailed product information.
Request sample Contact us

What is Thalassemia?

Thalassemia is an inherited (i.e., passed from parents to children through genes) blood disorder caused when the body doesn’t make enough of a protein called hemoglobin, an important part of red blood cells. Thalassemia is a treatable disorder that can be well-managed with blood transfusions and chelation therapy.1

Symptoms

The symptoms for the different types of thalassemia vary but may be an indication of the severity of the condition. Some symptoms are:2

  • Dizziness
  • Shortness of breath
  • A fast heart beat
  • Headache
  • Leg cramps
  • Difficulty concentrating
  • Pale skin

 

Please always consult healthcare professional for advice on thalassemia.

Causes

Thalassaemia is caused by faulty genes that a child inherits from their parents.

It's not caused by anything the parents did before or during the pregnancy, and you cannot catch it from someone who has it.3

Treatment of thalassemia 

Thalassemia usually requires lifelong treatment with blood transfusions and medicine. Chelation therapy is used for treatment to remove excess iron caused by regular blood transfusions. It’s very important because high levels of iron in the body can damage organs4.

One of the medications used to remove excess iron is deferoxamine mesylate. This medication is administered by subcutaneous infusion using an infusion pump and an infusion set which connects the pump device to the body.

In general, the treatment of thalassemia should always be based on a healthcare professional’s assessment of an individual patient’s situation.

Our Neria™ infusion sets

Neria™Guard and Neria™ infusion sets are tested for use with deferoxamine mesylate for treatment of thalassemia.

The choice of medication and method of administration relies on the assessment of the healthcare professionals.

Help with using our products

Neria™Guard and Neria™ infusion sets are built with ease of use in mind, but it's crucial to follow the advice of healthcare professionals and consult the Instructions For Use (IFU) when using an infusion set. Below you can find some basic information about using a Neria™Guard infusion set.

How to use the Neria™Guard infusion set

Watch our instruction video and quickly learn how to use the Neria™Guard infusion set

Our Infusion Therapy Areas

1. Centre for Disease Control and Prevention: cdc.gov. Reviewed February 1, 2024. Accessed February 15, 2024. Learn More About Thalassemia | CDC

2. Centre for Disease Control and Prevention: cdc.gov. Reviewed April 27, 2023. Accessed February 15, 2024. Thalassemia: Complications and Treatment | CDC

3. National Health Service (NHS): nhs.uk. Reviewed October 17, 2022. Accessed February 22, 2024. https://www.nhs.uk/conditions/thalassaemia/causes/

4.National Health Service (NHS): nhs.uk. Reviewed October 17, 2022. Accessed February 22, 2024. https://www.nhs.uk/conditions/thalassaemia/treatment/

Disclaimer: This page is for your reference only. To see website for local specific information, please visit your country's website.

The Convatec name, Hug icon and strapline are trademarks of Convatec.

AP-67786-GBL-ENG-V1 (v1.1)

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?